Singapore Intrauterine Contraceptive Devices Market Size & Outlook, 2025-2033

Singapore Intrauterine Contraceptive Devices Market Insights

As highlighted in Reed Intelligence analysis, the Singapore Intrauterine Contraceptive Devices Market, worth USD 13.21 Million in 2024, is forecasted to achieve USD 18.03 Million by 2033.
The Singapore market is anticipated to grow at a CAGR of 3.53% during the period 2025–2033.
By 2024, Hormonal Intrauterine Devices represented the largest share of the By Type market size.
Copper Intrauterine Devices is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

Other Key Findings

As of 2024, Singapore held 0.43% of the global Intrauterine Contraceptive Devices Market size.
By 2033, United States is anticipated to capture the largest share of the global Intrauterine Contraceptive Devices Market.
In Asia Pacific, China is expected to lead the regional Intrauterine Contraceptive Devices Market size by 2033.
South East Asia will remain the fastest-growing market in Asia Pacific, reaching USD 91.95 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 13.21 Million
Market Size In 2033	USD 18.03 Million
Largest segment	Hormonal Intrauterine Devices
Units	Revenue in USD Million
CAGR	3.53% (2025-2033)
Segmnetation Covered
By Type	Hormonal Intrauterine Devices Copper Intrauterine Devices
By Product	Mirena Skyla Paragard Essure Levosert Others
By End-User	Hospitals Gynecology Clinics Community Healthcare Centers
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Singapore Intrauterine Contraceptive Devices Market By Type 2025-2033 (USD Million)

By Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hormonal Intrauterine Devices	XX.x	XX.x	XX.x	7.27	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Copper Intrauterine Devices	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Singapore Intrauterine Contraceptive Devices Market By Product 2025-2033 (USD Million)

By Product	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Mirena	XX.x	XX.x	XX.x	4.71	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Skyla	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Paragard	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Essure	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Levosert	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Singapore Intrauterine Contraceptive Devices Market By End-User 2025-2033 (USD Million)

By End-User	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hospitals	XX.x	XX.x	XX.x	6.36	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Gynecology Clinics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Community Healthcare Centers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.